tirzepatide and mash in #VisualAbstract: Tirzepatide for Metabolic Dysfunction-Associated Steatohepatitis (MASH) with Liver Fibrosis was More Effective Than Placebo at Resolving MASH Tirzepatide: A Game-Changer for MASH

Specialized pharmacies create compounded versions rather than pharmaceutical manufacturing facilities

Trends in Molecular Medicine, 2005

Eine bewusste Dosierung ist der Schlssel zur sicheren Nutzung

These 2 drugs have in common long half-lives (~ 5 days), which affords once-weekly dosing, but have different mechanisms of action

Diabetologia 36:741744 Meier JJ, Ritter PR, Jacob A et al (2010) Impact of exogenous hyperglucagonemia on postprandial concentrations of gastric inhibitory polypeptide and glucagon-like peptide-1 in humans

This report has been organized into sections according to the research sub-questions: metabolic outcomes, cardiovascular outcomes, renal outcomes, and adverse effects